Limited Competition: Research Education Program for the Clinical and Translational Science Awards Program

The Limited Competition Research Education Program for the Clinical and Translational Science Awards Program is administered by the National Institutes of Health within the U.S. Department of Health and Human Services. This opportunity is part of the broader Clinical and Translational Science Award Program, which is a congressionally mandated initiative designed to accelerate the translation of scientific discoveries into practical applications that improve patient care and public health. The program supports a nationwide consortium of academic medical centers and research institutions that collaborate to move innovations from laboratory research into clinical and community settings. The primary purpose of this specific funding opportunity is to support educational activities that enhance and complement workforce training in biomedical, behavioral, and clinical research. The initiative focuses on strengthening the skills and knowledge of researchers involved in translational science, ensuring that the workforce is equipped to address complex health challenges. These educational programs are expected to align with and extend the capabilities of existing Clinical and Translational Science Award infrastructure, emphasizing interdisciplinary collaboration and practical application of research findings. Funding under this opportunity is provided as a grant and is categorized within the health funding domain. While specific funding amounts, award ceilings, and total program funding levels are not disclosed in the forecast, awards are expected to support structured educational programming, training modules, and workforce development initiatives. There is no cost sharing or matching requirement associated with this grant, allowing recipients to focus resources directly on program implementation. Funds are expected to be used in accordance with federal regulations outlined in the Public Health Service Act and applicable federal cost principles. Eligibility for this opportunity is restricted through a limited competition framework. Only organizations that have successfully received a Clinical and Translational Science Award under a specified prior funding announcement or its subsequent iterations are eligible to apply. This restriction ensures that applicants already possess the infrastructure and institutional capacity required to effectively deliver advanced research education programs. As such, the opportunity is primarily targeted at established academic medical centers and research institutions that are part of the existing CTSA network. The application process for this grant will follow standard National Institutes of Health procedures. Although the opportunity is currently in a forecast stage, it is expected that eligible organizations will be invited to submit applications once the official notice is released. Applications will undergo a rigorous peer review process in accordance with NIH standards, with funding decisions based on scientific merit and alignment with program objectives. Applicants will likely be required to submit detailed program descriptions, training plans, and evaluation strategies as part of their proposals. The timeline for this funding opportunity indicates that the official posting is anticipated in early September 2026, with an estimated application due date in late January 2027. Awards are expected to be issued in December 2027, with project activities commencing shortly thereafter. This extended timeline reflects the complexity of the review and selection process, as well as the need for careful planning and coordination among participating institutions. The opportunity appears to follow a recurring pattern aligned with NIH funding cycles, although specific recurrence details are not explicitly stated. For inquiries related to this funding opportunity, applicants are directed to contact the Division of Clinical Innovation within the National Center for Advancing Translational Sciences via email. This centralized contact point provides guidance and clarification for prospective applicants, ensuring that institutions can effectively prepare for submission once the opportunity is formally released. Overall, this grant represents a strategic investment in strengthening the national translational research workforce and advancing the impact of biomedical discoveries.